Sysmex XN-450
Sysmex Europe SEWith the XN-450 you can run single samples safely in closed mode. The instrument offers open mode too and comes with a fully integrated IPU, including an LCD colour touchscreen that makes it easy to operate.
With the XN-450 you can run single samples safely in closed mode. The instrument offers open mode too and comes with a fully integrated IPU, including an LCD colour touchscreen that makes it easy to operate.
Bio-Rad’s growing range of anti-idiotypic antibodies offers researchers enhanced flexibility for the development of custom bioanalytical drug assays
Acquisition enables Sartorius to continue to develop optimized systems for membrane-based chromatography technology
Sartorius acquires a majority stake in ALS Automated Lab Solutions
The new MDx system will efficiently access a wide array of Seegene's syndromic assays
Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new products which have made the most difference to clinical diagnostics
The partnership launches RoosterBio’s first international platform with off-the-shelf working cell banks and hMSC bioprocess media products in Asia
Features water-based testing strips and handheld reader delivering convenience and accuracy
Bio-Rad Laboratories has launched a range of anti-certolizumab pegol inhibitory antibodies to support the development of anti-drug antibody (ADA) assays
Special licensing terms enable rapid access to CHOSOURCE platform to streamline SARS-CoV-2 therapeutic development and production processes
Transaction adds comprehensive cell editing capabilities and engine to support expansion of Abcam’s existing portfolio of ‘off-the-shelf’ edited cell lines
Scientific, technological and communications excellence has been celebrated at the Clinical Science Summit, with Beckman Coulter, Zymo Research, and PerkinElmer among those recognized
Liverpool Accelerator Science Symposium considers growing importance and economic potential of particle colliders